English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background   ECMO is increasingly used for patients with critical illnesses. This study examines ECMO use in patients with cardiogenic shock in US hospitals and associated outcomes (mortality, hospital length of stay, and total hospital charges).Methods   A matched cohort retrospective study was conducted using the 2013 Nationwide Emergency Department Sample. Cardiogenic shock visits were matched (1 : 1) and compared based on ECMO use.Results   Patients with ECMO ( N  = 802) were compared to patients without ECMO ( N  = 805). Mortality was higher in the ECMO group (48.9% versus 4.0%,  p  < 0.001). Visits with ECMO use also had higher average hospital charges ($580,065.8 versus $156,436.5,  p  < 0.001) and average hospital LOS (21.3 versus 11.6 days,  p  < 0.001). After adjusting for confounders, mortality (OR = 8.52 (95% CI: 2.84–25.58)) and charges (OR = 1.03 (95% CI: 1.02–1.05)) remained higher in the ECMO group, while LOS was similar (OR = 1.01 (95% CI: 0.99–1.02)).Conclusions   Patients with cardiogenic shock who underwent ECMO had increased mortality and higher cost of care without significant increase in LOS when compared to patients with cardiogenic shock without ECMO use. Prospective evaluation of this observed association is needed to improve outcomes and resources' utilization further.

Outcomes in Cardiogenic Shock Patients with Extracorporeal Membrane Oxygenation Use: A Matched Cohort Study in Hospitals across the United States